Welcome Healthcare

+91 9821255501
dipesh@welcomeenterprises.co.in

Cizumab 100mg Bevacizumab


Bevacizumab, as it is generically called, is used for the treatment of metastatic colorectal cancer (mCRC). The product, which was launched under brand name Cizumab, has been approved by Drug Controller General of India (DCGI) and has been recommended as a first-line of treatment for mCRC. The product will be made available to patients in a single dose vial with two strengths. 
 
Specifications :
 
  • 100 mg and 400 mg

© 2017 | Welcome Healthcare

Powerd by: Webxces Technologies

Contact Us

Address: 
Welcome Healthcare,
A-9/8-B, Shriram Industrial Estate,
13, G. D. Ambedkar Road Wadala,
Mumbai - 400031, Maharashtra, India
+91 22 24181154